Table 5.
The 10 most suspicious drug–drug–adverse drug reaction (ADR) combinations detected by the additive and multiplicative model
| Drug combinations (A and B) | Adverse drug reaction | n | δ1 | P1 | δ2 | P2 | |
|---|---|---|---|---|---|---|---|
| Levodopa and benserazide | Amantadine | Ataxia | 4 | 0.8 | <0.001 | * | <0.001 |
| Levodopa and benserazide | Benzhexol | Neurosis | 6 | 0.78 | <0.001 | * | <0.001 |
| Tarceva | Gemcitabine | Diarrhoea | 5 | 0.66 | <0.001 | 6.91 | <0.001 |
| Mycophenolate mofetil | Ciclosporin | Constipation | 4 | 0.5 | 0.005 | * | <0.001 |
| Interferon alfa-2a | Ribavirin | Marrow suppression | 33 | 0.27 | <0.001 | 3.52 | <0.001 |
| Interferon alfa-2a | Ribavirin | Thyroid disorder | 21 | 0.21 | <0.001 | * | <0.001 |
| Azithromycin | Fleroxacin | Sleep disorder | 5 | 0.21 | 0.011 | 21.22 | <0.001 |
| Cefuroxime | Clindamycin | Local swelling | 4 | 0.21 | 0.027 | 13.44 | <0.001 |
| Mezlocillin | Penicillin sodium | Allergic reaction | 7 | 0.15 | 0.029 | 3.98 | <0.001 |
| Interferon alfa-2a | Ribavirin | Leucopenia | 17 | 0.12 | <0.001 | 1.67 | <0.001 |
δ1 and P1 represent the result of the additive model and δ2 and P2 represent the result of the multiplicative model. The meaning of
is as in Table 2.